Skip to main content
AI Market Summary
Loading market intelligence...

Myovant Sciences Ltd (MYOV) Stock Forecast 2025 - AI Price Prediction & Analysis


Myovant Sciences Ltd (MYOV) AI Stock Price Forecast & Investment Analysis

Myovant Sciences Ltd Stock Price Chart and Technical Analysis

Loading Myovant Sciences Ltd interactive price chart and technical analysis...

Myovant Sciences Ltd (MYOV) - Comprehensive Stock Analysis & Investment Research

Deep dive into Myovant Sciences Ltd's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Myovant Sciences Ltd, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Myovant Sciences Ltd: Myovant Sciences Ltd operates in the Manufacturing sector, establishing it as a mid-cap growth opportunity.

Myovant Sciences Ltd (Stock Symbol: MYOV) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 579 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Myovant Sciences Ltd's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Myovant Sciences Ltd: With $379M in annual revenue and -47.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $379 million generating a -47.6% net profit margin .

Market Capitalization: $2618 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -140.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Myovant Sciences Ltd stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Myovant Sciences Ltd: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Myovant Sciences Ltd stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Myovant Sciences Ltd's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Myovant Sciences Ltd: Market positioning analysis based on available financial and operational metrics.

Myovant Sciences Ltd strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

Myovant Sciences Ltd (MYOV) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Myovant Sciences Ltd stock analysis.

Loading Myovant Sciences Ltd comprehensive fundamental analysis and insider trading data...

Deep dive into Myovant Sciences Ltd's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Myovant Sciences Ltd stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Myovant Sciences Ltd: With a P/E ratio of -13.69, the market sees the stock as potentially undervalued.

P/E Ratio -13.69x
P/B Ratio -4.69x
Market Cap $2618M
EPS $-1.92
Book Value/Share $-5.75
FCF/Share $4.95
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Myovant Sciences Ltd converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Myovant Sciences Ltd: An ROE of -140.1% indicates room for improvement in shareholder value creation.

ROE -140.1%
ROA -33.1%
ROIC -279.4%
Operating Margin -38.8%
Net Margin -47.6%
EBT Margin -87.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Myovant Sciences Ltd's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Myovant Sciences Ltd: A current ratio of 1.95 shows adequate liquidity.

Current Ratio 1.95x
Quick Ratio 1.83x
D/E Ratio 21.51x
Financial Leverage 39.91x
Interest Coverage -13.4x
Working Capital $423M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Myovant Sciences Ltd's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Myovant Sciences Ltd: Free cash flow of $-270M indicates cash challenges that need attention.

Operating Cash Flow $-269M
Free Cash Flow $-270M
Capital Spending $-1M
FCF/Sales -116.7%
CapEx/Sales 0.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Myovant Sciences Ltd uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Myovant Sciences Ltd: An asset turnover of 0.37x suggests room for improvement in asset utilization.

Asset Turnover 0.37x
Receivables Turnover 17.2x
Inventory Turnover 10.1x
Fixed Assets Turnover 19.4x
Days Sales Outstanding 21 days
Days Inventory 36 days
Payables Period 106 days
Cash Conversion Cycle -49 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Myovant Sciences Ltd's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Myovant Sciences Ltd: With annual revenue of $379M, Myovant Sciences Ltd demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $379M
Operating Income $-146M
Net Income $-180M
R&D Expense $107M
SG&A Expense $112M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 94%
Cash & Short-term Investments 84%
Total Liabilities 191%
Short-term Debt 4%
Accounts Receivable 5%
Inventory 1%
Dividend & Shareholder Information
Shares Outstanding 97M
Growth Metrics (YoY)
EPS Growth -7.1%

Latest Myovant Sciences Ltd Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Myovant Sciences Ltd (MYOV) stock price and investment outlook.

, source: Benzinga.com

Myovant Sciences Ltd MYOV shares are trading higher Monday after the company announced it will be acquired by Sumitovant Biopharma for $27 per share in cash. Sumitovant and its subsidiaries entered ...

, source: BioWorld

Sumitovant Biopharma Ltd., a subsidiary of Sumitomo Pharma Co. Ltd., agreed to acquire Myovant Sciences Ltd. for $27 per share, up from its earlier offer of $22.75 per share. The deal is worth $1.7 ...

, source: Reuters

Japan's Sumitomo Pharma to buy rest of Myovant in sweetened deal Japan's Sumitomo Pharma Co and its subsidiary said on Sunday they would purchase the remaining shares of Myovant Sciences at an ...

Myovant Sciences Ltd Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Myovant Sciences Ltd against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Myovant Sciences Ltd Stock Forecast

How accurate are Myovant Sciences Ltd stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for MYOV predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Myovant Sciences Ltd stock price forecasts?

Our analysis considers Myovant Sciences Ltd's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Myovant Sciences Ltd a good investment in 2025?

Based on our AI analysis, Myovant Sciences Ltd shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Myovant Sciences Ltd forecasts updated?

Myovant Sciences Ltd stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Myovant Sciences Ltd Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Myovant Sciences Ltd stock.

My Portfolio

Investment Dashboard

Loading your portfolio...